Genomic Endometrial Expression in Obesity

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00505986

Enrollment

Unknown

Registered

2007-07-25

Start date

2007-06-30

Completion date

2009-05-31

Last updated

2012-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and Embryo Implantation

Brief summary

Determine if different genomic endometrial expression exists during embryo implantation in obese women in comparison with non obese women.

Interventions

PROCEDUREendometrial biopsy

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* group A: non obese oocyte donors (BMI: 18 - 29 kg. /m2)with proven fertility * group B: obese oocyte donors: (BMI: \>29 kg./m2)with proven fertility * group C: obese (BMI: \>29 kg./m2) infertile patients,

Exclusion criteria

* recurrent miscarriage

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026